Hui Dong

1.0k total citations
55 papers, 735 citations indexed

About

Hui Dong is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Hui Dong has authored 55 papers receiving a total of 735 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 11 papers in Surgery and 11 papers in Oncology. Recurrent topics in Hui Dong's work include Cancer Research and Treatments (4 papers), Cancer, Lipids, and Metabolism (4 papers) and MicroRNA in disease regulation (3 papers). Hui Dong is often cited by papers focused on Cancer Research and Treatments (4 papers), Cancer, Lipids, and Metabolism (4 papers) and MicroRNA in disease regulation (3 papers). Hui Dong collaborates with scholars based in China, Germany and United States. Hui Dong's co-authors include Rui Gou, Bei Lin, Yuexin Hu, Erlin Zhang, Xiaowei Tang, Shibing Wang, Mingjun Zheng, Chen Yang, Xiaoyan Wang and Dafu Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Journal of Hepatology.

In The Last Decade

Hui Dong

51 papers receiving 728 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hui Dong China 16 277 178 165 92 87 55 735
Zahra‐Soheila Soheili Iran 18 600 2.2× 124 0.7× 146 0.9× 68 0.7× 93 1.1× 94 1.0k
Shuangba He China 13 152 0.5× 179 1.0× 65 0.4× 105 1.1× 154 1.8× 33 742
Ioan Ştefan Florian Romania 16 310 1.1× 90 0.5× 188 1.1× 85 0.9× 182 2.1× 78 897
Adriana Harbuzariu United States 17 328 1.2× 130 0.7× 144 0.9× 62 0.7× 162 1.9× 35 749
Toshiyuki Kaidoh Japan 13 633 2.3× 250 1.4× 295 1.8× 76 0.8× 73 0.8× 29 1.1k
Giovanna M. Crisi United States 16 247 0.9× 143 0.8× 183 1.1× 48 0.5× 275 3.2× 43 1.1k
Maya Sakamoto Japan 19 242 0.9× 298 1.7× 61 0.4× 72 0.8× 178 2.0× 65 1.2k
Manuel Fischer Germany 18 476 1.7× 178 1.0× 37 0.2× 61 0.7× 84 1.0× 75 1.1k
Suganth Suppiah Canada 16 140 0.5× 84 0.5× 76 0.5× 86 0.9× 102 1.2× 35 930
Zhonglin Liu United States 14 378 1.4× 70 0.4× 114 0.7× 32 0.3× 65 0.7× 39 716

Countries citing papers authored by Hui Dong

Since Specialization
Citations

This map shows the geographic impact of Hui Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Dong more than expected).

Fields of papers citing papers by Hui Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Dong. The network helps show where Hui Dong may publish in the future.

Co-authorship network of co-authors of Hui Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Dong. A scholar is included among the top collaborators of Hui Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Dong. Hui Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Shiwei, et al.. (2025). Global research trends on nanotechnology and colorectal cancer: a two-decade analysis. Nanomedicine. 20(4). 343–354. 1 indexed citations
2.
Dong, Hui, et al.. (2025). Value Analysis of Preoperative Peripheral Blood Markers in the Identification of Benign From Malignant Parotid Gland Tumors. International Dental Journal. 75(4). 100854–100854.
3.
4.
5.
Su, Hao, Yueheng Tang, Kexin Nie, et al.. (2022). Identification Prognostic Value and Correlation with Tumor-Infiltrating Immune Cells of Tripartite-Motif Family Genes in Hepatocellular Carcinoma. SHILAP Revista de lepidopterología. 10 indexed citations
6.
Yang, Chen, Hui Dong, Xianglei He, et al.. (2022). The correlation of fibrinogen-like protein-1 expression with the progression and prognosis of hepatocellular carcinoma. Molecular Biology Reports. 49(8). 7911–7919. 14 indexed citations
7.
Zhang, Haidong, Hui Dong, Zheng Pan, et al.. (2022). Risk factors and predictive nomograms for early death of patients with pancreatic cancer liver metastasis: A large cohort study based on the SEER database and Chinese population. Frontiers in Oncology. 12. 998445–998445. 2 indexed citations
8.
Lu, Tao, Hairong Xu, Wei Dong, & Hui Dong. (2022). Expression and prognosis analysis of PAQR5 in kidney cancer. Frontiers in Oncology. 12. 955510–955510. 3 indexed citations
9.
Gao, Hongwei, et al.. (2022). LINC01119 negatively regulates osteogenic differentiation of mesenchymal stem cells via the Wnt pathway by targeting FZD4. Stem Cell Research & Therapy. 13(1). 43–43. 11 indexed citations
10.
Dong, Hui, Wenyan Chen, Bin Wang, et al.. (2022). Case Report: Heterogeneity of Resistance Mechanisms in Different Lesions Co-Mediate Acquired Resistance to First-Line Icotinib in EGFR Mutant Non-Small Cell Lung Cancer. Frontiers in Medicine. 9. 906364–906364. 1 indexed citations
11.
Cheng, Gang, Hui Dong, Chen Yang, et al.. (2021). A review on the advances and challenges of immunotherapy for head and neck cancer. Cancer Cell International. 21(1). 406–406. 47 indexed citations
12.
Gao, Lingling, Xin Nie, Rui Gou, et al.. (2021). Exosomal ANXA2 derived from ovarian cancer cells regulates epithelial‐mesenchymal plasticity of human peritoneal mesothelial cells. Journal of Cellular and Molecular Medicine. 25(23). 10916–10929. 33 indexed citations
13.
Hu, Yuexin, Mingjun Zheng, Shuang Wang, et al.. (2021). Identification of a five-gene signature of the RGS gene family with prognostic value in ovarian cancer. Genomics. 113(4). 2134–2144. 43 indexed citations
14.
Gou, Rui, Yuexin Hu, Ouxuan Liu, et al.. (2021). PGK1 Is a Key Target for Anti-Glycolytic Therapy of Ovarian Cancer: Based on the Comprehensive Analysis of Glycolysis-Related Genes. Frontiers in Oncology. 11. 682461–682461. 24 indexed citations
15.
Dong, Hui, Wenyang Zhou, Pingping Wang, et al.. (2020). Comprehensive Analysis of the Genetic and Epigenetic Mechanisms of Osteoporosis and Bone Mineral Density. Frontiers in Cell and Developmental Biology. 8. 194–194. 10 indexed citations
16.
Tang, Xiaowei, Chao Zhou, Ju Gao, et al.. (2019). Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunction. BMC Psychiatry. 19(1). 254–254. 26 indexed citations
17.
Ye, Fei, Xiaowei Tang, Jin Li, et al.. (2018). Altered serum levels of vascular endothelial growth factor in first-episode drug-naïve and chronic medicated schizophrenia. Psychiatry Research. 264. 361–365. 9 indexed citations
18.
Ye, Fei, et al.. (2018). Baseline serum vascular endothelial growth factor levels predict treatment response to antipsychotic medication in patients with schizophrenia. European Neuropsychopharmacology. 28(5). 603–609. 14 indexed citations
19.
20.
Zhang, Erlin, et al.. (2015). Biocompatibility of antibacterial Ti–Cu sintered alloy: in vivo bone response. Journal of Materials Science Materials in Medicine. 26(12). 265–265. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zahra‐Soheila Soheili Breakdown of academic impact, for papers by Shuangba He Breakdown of academic impact, for papers by Ioan Ştefan Florian Breakdown of academic impact, for papers by Adriana Harbuzariu Breakdown of academic impact, for papers by Toshiyuki Kaidoh Breakdown of academic impact, for papers by Giovanna M. Crisi Breakdown of academic impact, for papers by Maya Sakamoto Breakdown of academic impact, for papers by Manuel Fischer Breakdown of academic impact, for papers by Suganth Suppiah Breakdown of academic impact, for papers by Zhonglin Liu
Rankless by CCL
2026